Table 3.
Comparison of the preoperative characteristics, co-morbidities, and medication data for the study population. IBW, ideal body weight
| Total | Non-event | All-event | P-value | |
|---|---|---|---|---|
| Characteristic | ||||
| Patients (n) | 32 | 16 | 16 | |
| Age (yr) | 63 (22–80) | 63 (38–80) | 63 (22–78) | |
| Gender (M/F) | 21/11 | 11/5 | 10/6 | 1.00 |
| Weight (kg) | 83 (55–167) | 80 (67–129) | 84 (55–167) | |
| Predicted IBW (kg) | 77 (53–90) | 78 (52–88) | 80 (61–90) | |
| Co-morbidities | ||||
| Cardiovascular disease | 16 (50.0%) | 8 | 8 (50.0%) | 1.00 |
| Hypertension | 14 (43.7%) | 7 | 7 (50.0%) | 1.00 |
| Diabetes mellitus | 5 (15.6%) | 1 | 4 (80.0%) | 0.033 |
| Respiratory disease | 3 (9.4%) | 2 | 1 (33.3%) | 1.00 |
| Chemotherapy | 21 (65.6%) | 11 | 10 | 1.00 |
| Radiotherapy | 9 (28.1%) | 4 | 5 | 1.00 |
| Preoperative medication | ||||
| β-blockers | 5 (15.6%) | 0 | 5 | 0.04 |